GAUDIO, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 5.246
AS - Asia 2.341
EU - Europa 2.191
SA - Sud America 565
AF - Africa 347
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 10.701
Nazione #
US - Stati Uniti d'America 5.048
SG - Singapore 1.086
CN - Cina 740
IT - Italia 621
IE - Irlanda 553
UA - Ucraina 493
BR - Brasile 489
CI - Costa d'Avorio 264
IN - India 205
CA - Canada 173
RU - Federazione Russa 134
VN - Vietnam 119
SE - Svezia 80
DE - Germania 75
FR - Francia 57
KR - Corea 50
GB - Regno Unito 46
SN - Senegal 34
FI - Finlandia 28
AR - Argentina 27
CH - Svizzera 20
UZ - Uzbekistan 19
BD - Bangladesh 17
NG - Nigeria 17
HK - Hong Kong 14
JP - Giappone 14
MX - Messico 14
NL - Olanda 14
EC - Ecuador 13
ZA - Sudafrica 13
GR - Grecia 12
IQ - Iraq 12
TR - Turchia 12
CO - Colombia 9
ID - Indonesia 9
PL - Polonia 9
PY - Paraguay 9
AT - Austria 8
EU - Europa 8
IR - Iran 8
MA - Marocco 7
AE - Emirati Arabi Uniti 6
ES - Italia 6
LT - Lituania 6
PE - Perù 6
BG - Bulgaria 5
HU - Ungheria 5
KZ - Kazakistan 5
SA - Arabia Saudita 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
IL - Israele 4
KE - Kenya 4
LB - Libano 4
RS - Serbia 4
CL - Cile 3
HN - Honduras 3
HR - Croazia 3
PK - Pakistan 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
OM - Oman 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MK - Macedonia 1
NP - Nepal 1
PF - Polinesia Francese 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
Totale 10.701
Città #
Dallas 1.041
Santa Clara 832
Dublin 553
Singapore 552
Chandler 512
Jacksonville 406
Abidjan 264
Boardman 245
Chicago 193
Cambridge 154
Lawrence 154
Kochi 148
Andover 147
Nanjing 144
Catania 139
Ashburn 131
Hefei 117
Toronto 114
Beijing 86
Des Moines 74
Wilmington 74
San Mateo 63
Seoul 50
Ottawa 46
Ho Chi Minh City 45
Saint Petersburg 40
São Paulo 39
Civitanova Marche 36
Nanchang 36
Shenyang 36
Hebei 35
Dakar 34
Palermo 32
Jiaxing 31
Los Angeles 28
Bremen 27
New York 27
Milan 24
Changsha 21
Lappeenranta 21
Modica 21
Hanoi 20
Seattle 20
Tianjin 19
Munich 18
Rio de Janeiro 18
Abuja 16
Padova 16
Brasília 15
Pune 15
Rome 15
Houston 14
Tokyo 14
Columbus 13
Hangzhou 13
Phoenix 12
The Dalles 12
Washington 12
Belo Horizonte 11
Civitavecchia 11
Mascalucia 11
Nocera Inferiore 11
Norwalk 11
Falls Church 10
Hong Kong 10
Moscow 10
Atlanta 9
Caltanissetta 9
Campinas 9
Messina 9
Ann Arbor 8
Boston 8
Council Bluffs 8
Dong Ket 8
Redondo Beach 8
Redwood City 8
Chennai 7
Frankfurt am Main 7
Mexico City 7
Mumbai 7
Tehran 7
Ankara 6
Guarulhos 6
Johannesburg 6
London 6
Ningbo 6
Salvador 6
Tashkent 6
Baghdad 5
Budapest 5
Buffalo 5
Carapicuíba 5
Casalecchio di Reno 5
Frankfurt Am Main 5
Giarre 5
Guayaquil 5
Haiphong 5
Hải Dương 5
Jinan 5
Lausanne 5
Totale 7.340
Nome #
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 143
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 138
A rare cause of leg pain 138
A systematic review of arterial stiffness, wave reflection and air pollution 128
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 124
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 114
Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect 110
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 106
Anticoagulants and osteoporosis 102
Augmentation index is increased in patients with inflammatory bowel disease, a meta-analysis 98
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 97
A suspicious fracture 97
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 94
Deep vein thrombosis related to environment (Review) 94
Correlation between family history of hypertension and haemostatic disorders 92
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 92
Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and causal associations in transversal studies: The time-series analysis to reveal potential confounders. comment on “gaudio et al. vitamin d levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients. Int. j. environ. res. public health 2021, 18, 3491” 92
Vitamin D levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients 90
Alterazioni emostatiche in pazienti con arteriopatia obliterante periferica con e senza diabete 88
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 88
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 86
A strange case of dyspnoea 86
Melorheostosis and Osteopoikilosis Clinical and Molecular Description of an Italian Case Series 85
Bisphosphonates in the treatment of thalassemia-associated osteoporosis 84
Dehydroepiandrosterone (DHEA) replacement therapy in elderly men with osteoporosis 84
Oxidative stress in peripheral arterial disease (PAD) mechanism and biomarkers 84
Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study 84
Effetti del raloxifene sulla densità del parenchima mammario 83
Biphosphonates prevent bone loss in thalassemia major patients 82
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 82
Paget's Disease of Bone and Cardiovascular Risk: a Pilot Study 82
Apparato locomotore 80
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study 78
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 78
Peripheral artery disease and osteoporosis: Not only age-related (Review) 78
Donne in post-menopausa in trattamento farmacologico per la prevenzione primaria delle fratture osteoporotiche: primi dati di uno studio pilota su aderenza e persistenza alla terapia 78
Bone islands. 78
Raloxifene e rischio cardiovascolare 77
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 76
Review: UPDATE sul metabolismo del magnesio 76
Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease 76
Vascular dysfunction in Cardiorenal Syndrome type 4 76
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? 76
Paget's bone disease is not always the culprit 75
Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism 75
Hematological Diseases and Osteoporosis 74
Insights from experiences on antiplatelet drugs in stroke prevention: A review 74
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 74
Vascular dysfunction of COVID-19 is partially reverted in the long-term 74
It Is Time for a Routine Measurement of Aortic Stiffness in Inflammatory Bowel Disease 73
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 73
Osteoporosis and beta-thalassemia major: Role of the IGF-I/IGFBP-III axis 73
Heredity of the haemostatic disorders in non insulin dependent diabetes (NIDDM) 73
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience 73
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 72
Relationships between osteoprotegerin, receptor activator of the nuclear factor kB ligand and serum levels and carotid intima-media thickness in patients with type 2 diabetes mellitus. 71
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 70
When the FRAX® test is applied to controlled clinical trials 69
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis 67
Dehydroepiandrosterone replacement therapy prevents male senile bone loss 67
More is not better 67
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 67
Handgrip strength to discriminate high fracture risk in type 2 diabetes mellitus patients. 67
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 67
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus 66
Osteoprotegerina ed osteoporosi nei thalassemici 66
Effetti della somministrazione di EPO sul metabolismo osseo nel ratto 66
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate 65
The relationship between inhibitors of the Wnt signaling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus 65
Effetti del raloxifene sulla secrezione ipofisaria 65
I bifosfonati prevengono la perdita d'osso nei pazienti thalassemici 65
What changed in the Italian internal medicine and geriatric wards during the lockdown 65
Successful neridronate therapy in pregnancy-associated osteoporosis 64
Hemostatic changes in vasculitides 64
Effetto del pattern genetico sulla BMD in pazienti talassemici: analisi preliminare 64
Livelli sierici di osteoprotegerina e markers del turnover osseo durante il trattamento con raloxifene: dati preliminari 64
Raloxifene and pituitary secretion in post-menopausal women 64
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 63
Il neridronato previene il bone loss durante la terapia antiandrogena per il cancro prostatico 63
Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women 63
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 62
Riduzione della densità minerale volumetrica in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 62
Effects of agonistic physical activity on the activation of WNT/beta-catenin signaling 62
Role of genetic pattern on bone mineral density in thalassemic patients 62
Vitamin d boosts alendronate tail effect on bone mineral density in postmenopausal women with osteoporosis 62
Haemostatic effects of phytoestrogen genistein in postmenopausal women 61
Ridotta risposta terapeutica all' alendronato in pazienti depresse affette da osteoporosi 61
Livelli circolanti di citochine osteotrope e rimodellamento osseo nei pazienti thalassemici 61
Rete Osteoporosi Sicilia (Sicilian Osteoporosis Network): an IT platform for the improvement of diagnosis and treatment of osteoporosis in Sicily. 61
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 61
Response to Letter to the Editor: "Methodological Issues Regarding Cortisol Secretion, Sensitivity, and Activity are Associated With Hypertension in Postmenopausal Eucortisolemic Women" 60
Pain and Frailty in Hospitalized Older Adults 60
Therapeutic Options in the Management of Aromatase Inhibitor-Associated Bone Loss 60
An unusual bilateral groin pain after COVID-19 infection in an 82-year-old man 60
Hemostatic effects of diets containing olive or soy oil in hypertensive patients 59
Raloxifene effects on cardiovascular risk 59
Effects of administration of Dehydroepiandrosterone (DHEA) on male senile osteoporosis 59
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 59
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 58
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 58
Totale 7.708
Categoria #
all - tutte 42.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021665 0 0 0 0 245 38 100 8 74 49 104 47
2021/20221.117 112 156 14 20 184 15 162 43 102 2 59 248
2022/20231.705 164 66 22 143 189 308 7 261 418 27 46 54
2023/2024802 38 141 49 38 38 177 6 55 2 30 130 98
2024/20253.002 18 428 151 96 673 380 55 124 156 346 341 234
2025/20262.455 332 253 1.191 477 202 0 0 0 0 0 0 0
Totale 11.041